Enevoldsen, F.C.; Sahana, J.; Wehland, M.; Grimm, D.; Infanger, M.; Krüger, M.
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy. J. Clin. Med. 2020, 9, 824.
https://doi.org/10.3390/jcm9030824
AMA Style
Enevoldsen FC, Sahana J, Wehland M, Grimm D, Infanger M, Krüger M.
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy. Journal of Clinical Medicine. 2020; 9(3):824.
https://doi.org/10.3390/jcm9030824
Chicago/Turabian Style
Enevoldsen, Frederik C., Jayashree Sahana, Markus Wehland, Daniela Grimm, Manfred Infanger, and Marcus Krüger.
2020. "Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy" Journal of Clinical Medicine 9, no. 3: 824.
https://doi.org/10.3390/jcm9030824
APA Style
Enevoldsen, F. C., Sahana, J., Wehland, M., Grimm, D., Infanger, M., & Krüger, M.
(2020). Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy. Journal of Clinical Medicine, 9(3), 824.
https://doi.org/10.3390/jcm9030824